Moreover, the combination of ICIs and chemotherapy could synergistically induce antigen-specific immunity and enhance the infiltration of CD8+, and CD4+FoxP3 T cells to the tumor microenvironment (27). The gene discussed is CD4; the disease is neoplasm.